Stuart A. Arbuckle serves as Executive at VERTEX PHARMACEUTICALS INC / MA, where they oversee executive responsibilities. Since joining the company, Stuart A. Arbuckle has executed 395 insider transactions totaling $139.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 5, 2026 involved receiving (via award) 3,279 shares valued at $0.
Stuart A. Arbuckle currently holds 3,279 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stuart A. Arbuckle has been a net seller of VRTX stock. They have purchased $0 and sold $139.9M worth of shares.
Stuart A. Arbuckle's most recent insider trade was on Jan 5, 2026, when they sold 3,279 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $450.23 |
| Discretionary |
| Jun 21, 2024 | RYTM | $0 | Option Exercise | 3,000 | $N/A | Discretionary |
| May 15, 2024 | VRTX | $29.7K | Sale | 69 | $430.93 | Planned |
| Feb 26, 2024 | VRTX | $2.1M | Sale | 5,034 | $425.70 | Planned |
| Feb 23, 2024 | VRTX | $2.0M | Payment | 4,714 | $431.79 | Planned |
| Feb 21, 2024 | VRTX | $1.5M | Sale | 3,603 | $421.77 | Planned |
| Feb 20, 2024 | VRTX | $1.4M | Payment | 3,373 | $420.58 | Planned |
| Feb 20, 2024 | VRTX | $2.0M | Sale | 4,804 | $420.79 | Planned |
| Feb 16, 2024 | VRTX | $1.9M | Payment | 4,499 | $424.01 | Planned |
| Feb 12, 2024 | IMGN | $0 | Disposition | 5,381 | $N/A | Discretionary |
| Feb 12, 2024 | VRTX | $1.8M | Sale | 4,295 | $420.24 | Planned |
| Feb 9, 2024 | VRTX | $1.3M | Payment | 3,177 | $422.74 | Planned |
| Feb 7, 2024 | VRTX | $0 | Award | 8,448 | $N/A | Discretionary |
| Feb 6, 2024 | VRTX | $0 | Award | 11,210 | $N/A | Discretionary |
| Feb 6, 2024 | VRTX | $0 | Award | 6,976 | $N/A | Discretionary |
| Dec 29, 2023 | IMGN | $13.1K | Award | 442 | $29.65 | Discretionary |
| Dec 13, 2023 | VRTX | $3.4M | Sale | 8,603 | $399.00 | Planned |
| Dec 13, 2023 | VRTX | $1.6M | Option Exercise | 8,603 | $187.53 | Planned |
| Sep 29, 2023 | IMGN | $13.1K | Award | 827 | $15.87 | Discretionary |
| Jun 30, 2023 | IMGN | $13.1K | Award | 695 | $18.87 | Discretionary |
| Jun 15, 2023 | VRTX | $3.0M | Sale | 8,603 | $349.00 | Planned |
| Jun 15, 2023 | VRTX | $1.6M | Option Exercise | 8,603 | $187.53 | Planned |
| May 30, 2023 | VRTX | $27.0K | Sale | 82 | $329.82 | Planned |
| Mar 31, 2023 | IMGN | $13.1K | Award | 3,417 | $3.84 | Discretionary |
| Feb 27, 2023 | VRTX | $1.1M | Sale | 3,834 | $287.16 | Discretionary |
| Feb 27, 2023 | VRTX | $115.0K | Sale | 400 | $287.59 | Discretionary |
| Feb 27, 2023 | VRTX | $231.1K | Sale | 800 | $288.92 | Discretionary |
| Feb 24, 2023 | VRTX | $1.4M | Payment | 4,714 | $289.12 | Discretionary |
| Feb 22, 2023 | VRTX | $59.3K | Sale | 200 | $296.31 | Discretionary |